(90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies von Picozzi, Vincent J, Ramanathan, Ramesh K, Lowery, Maeve A, Ocean, Allyson J, Mitchel, Edith P, O'Neil, Bert H, Guarino, Michael J, Conkling, Paul R, Cohen, Steven J, Bahary, Nathan, Frank, Richard C, Dragovich, Tomislav, Bridges, Benjamin B, Braiteh, Fadi S, Starodub, Alexander N, Lee, Fa-Chyi, Gribbin, Thomas E, Richards, Donald A, Lee, Marie, Korn, Ronald L, Pandit-Taskar, Neeta, Goldsmith, Stanley J, Intenzo, Charles M, Sheikh, Arif, Manzone, Timothy C, Horne, Heather, Sharkey, Robert M, Wegener, William A, O'Reilly, Eileen M, Goldenberg, David M, Von Hoff, Daniel D

Volltext

90 Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies von Picozzi, Vincent J, Ramanathan, Ramesh K, Lowery, Maeve A, Ocean, Allyson J, Mitchel, Edith P, O’Neil, Bert H, Guarino, Michael J, Conkling, Paul R, Cohen, Steven J, Bahary, Nathan, Frank, Richard C, Dragovich, Tomislav, Bridges, Benjamin B, Braiteh, Fadi S, Starodub, Alexander N, Lee, Fa-Chyi, Gribbin, Thomas E, Richards, Donald A, Lee, Marie, Korn, Ronald L, Pandit-Taskar, Neeta, Goldsmith, Stanley J, Intenzo, Charles M, Sheikh, Arif, Manzone, Timothy C, Horne, Heather, Sharkey, Robert M, Wegener, William A, O’Reilly, Eileen M, Goldenberg, David M, Von Hoff, Daniel D

Volltext

Abstract B98: Final results of a randomized phase Ib study of fractionated 90Y-clivatuzumab tetraxetan in patients with metastatic pancreatic cancer having at least two prior thera... von Picozzi, Vincent J., Ramanathan, Ramesh K., Lowery, Maeve A., Ocean, Allyson J., Mitchell, Edith P., O'Neil, Bert H., Guarino, Michael J., Conkling, Paul R., Cohen, Steven J., Bahary, Nathan, Frank, Richard C., Dragovich, Tomislav, Bridges, Benjamin B., Lee, Marie, Korn, Ronald L., Pandit-Taskar, Neeta, Goldsmith, Stanley J., Intenzo, Charles M., Sheikh, Arif, Manzone, Timothy C., Miller, Michael L., Yu, Michael, Joyce, Judith M., Strauss, Edward B., Passalaqua, Susan, Dorn, Ronald V., Anderson, Michael J., Holt, Michael, Braiteh, Fadi S., Lee, Fa-Chyi, Gribbin, Thomas E., Richards, Donald A., Starodub, Alexander N., William, Wegener A., O'Reilly, Eileen M., Hoff, Daniel D. Von, Goldenberg, David M.

Volltext

90Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies von Picozzi, Vincent J., Ramanathan, Ramesh K., Lowery, Maeve A., Ocean, Allyson J., Mitchel, Edith P., O’Neil, Bert H., Guarino, Michael J., Conkling, Paul R., Cohen, Steven J., Bahary, Nathan, Frank, Richard C., Dragovich, Tomislav, Bridges, Benjamin B., Braiteh, Fadi S., Starodub, Alexander N., Lee, Fa-Chyi, Gribbin, Thomas E., Richards, Donald A., Lee, Marie, Korn, Ronald L., Pandit-Taskar, Neeta, Goldsmith, Stanley J., Intenzo, Charles M., Sheikh, Arif, Manzone, Timothy C., Horne, Heather, Sharkey, Robert M., Wegener, William A., O’Reilly, Eileen M., Goldenberg, David M., Von Hoff, Daniel D.

Volltext

Utility of diagnostic whole-body iodine scanning in high-risk differentiated thyroid carcinoma von Dam, Hung Q, Manzone, Timothy A, Grady, Erin C, Tulchinsky, Mark

Volltext

Indium-111 Leukocyte Scintigraphy Aids in Diagnosis of Tubo-Ovarian Abscess von Kushen, Medina C, Dam, Hung Q, Manzone, Timothy A

Volltext

Utility of Diagnostic Whole-Body Iodine Scanning in High-Risk Differentiated Thyroid Carcinoma/REPLY von Dam, Hung Q, Manzone, Timothy A, Grady, Erin C, Tulchinsky, Mark, de Meer, Siegrid G, Vriens, Menno R, Zelissen, Pierre M, Rinkes, Inne H Borel, de Keizer, Bart

Volltext